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Introduction
Liver transplantation is considered the treatment of choice for end-stage liver disease. Liver transplantation programs have expanded over the years, which indirectly has led to donor-liver shortage. Therefore, it is of vital importance to optimize the use of the available donor livers. Consequently, adequate function test(s) are needed to provide an objective basis for decision-making. However, such adequate function tests for donor livers are still lacking 1, 2 and this leads to unnecessary rejection of potential viable livers and the transplantation of non-viable livers, resulting in initial poor function or primary non-function.
In some reports a relationship between lidocaine clearance, measured as MEGX test, in the donor and the graft outcome was shown 3, 4 . However, others did not 71 find such a relation and therefore the MEGX test did not reach the status of "gold standard" 1 . Recently, it has been investigated whether in vitro preparations of the human liver could be used as predictor of transplantation success. We showed that liver needle biopsies can be used to isolate hepatocytes and subsequently to study the uptake rate of taurocholic acid 5 . However, this parameter did not seem to show correlation with graft function. In the latter study the number of experiments was rather low and no initial poor function or primary non-function of the transplanted livers occurred. In another study from our institute 6 , the metabolism of lidocaine was determined in needle biopsies of human livers.
The latter study showed a trend in predicting transplantation success. Groothuis et al. 7 isolated hepatocytes from tissue obtained from reduced size or split liver transplantations and livers discarded for transplantation, but could not detect any differences in viability or yield of the cells. In this study the results of the experiments obtained with hepatocytes could not be correlated with the success of transplantation of the part of the organ that was transplanted, since no dysfunction of the transplanted grafts was observed in this particular group of patients.
In the present study, residual tissue remaining after reduced size and split liver transplantations was used to prepare isolated hepatocytes and liver slices. In the liver slices, the original structure of the liver is retained. This integrated in vitro liver system may be a better predictor of the liver in vivo, than are isolated hepatocytes. The viability of these in vitro preparations was compared with the function of the transplanted graft in the host, up to 7 days after transplantation, in order to investigate if any of the tests performed in vitro could be related to graft function measured in the recipient. To give an indication of the viability of the cells present in the liver, the viability was tested by trypan blue exclusion and total yield of hepatocytes isolated from the human liver and the yield of viable cells after Percoll density centrifugation of the obtained cell suspensions was also determined. The slice viability was assessed by the measurement of potassium concentration in the liver slice. The energy status of the hepatocytes was studied by ATP concentration and the ability of the cells to synthesize ATP. The transport of the anionic bile acid taurocholic acid in human hepatocytes was studied to obtain information on the transport capacity of the hepatocytes in the human liver.
The metabolism of lidocaine in hepatocytes and liver slices was used to assess the metabolic capacity of the hepatocytes in the donor organ. These in vitro measured parameters may also give more insight into the mechanisms of primary non-function.
Prediction of liver function after transplantation
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Materials and Methods
Materials
The following compounds were obtained from the indicated sources: collagenase 
Liver material
Human liver tissue was obtained from livers procured from multi-organ donors.
Consent from the legal authorities and from the families concerned was 
Methods
Classification of transplant patients
Recipients were 19 males and 14 females in the age of 3 weeks to 26 years (median= 2.5 years). In all recipients routine liver function tests were performed after transplantation for seven consecutive days. Parameters included in this study were determination in serum of glutamate-oxal-acetate-transaminase (GOT), glutamate-pyruvate-transaminase (GPT), protrombin time (PTT) and antithrombin III (ATIII). In addition, the bile production was monitored as well as the amount of blood transfusions needed. Apart from these continuous variables, donor livers were grouped with regard to post-operative liver function according to the method as described by Ploeg et al. 8 . Initial poor function was defined as occurring in patients with serum GOT >2000 U/l, PTT >16 sec and ammonia levels >50 µmol/l on post-transplant days 2-7 and in addition all patients with primary non-function. Primary non-function was defined by Ploeg et al. 8 as patient or graft loss in 2-7 days after transplantation.
The definition of primary non-function is very strict and implies that also patients that might have suffered from graft loss or died as a result of causes not related to the liver function were included in the group of primary non-function.
For instance: according to the definition a patient dying on day 5 from a ruptured splenic artery aneurysm will be classified as a primary non-function, despite the fact that the graft functioned perfectly well. In order not to obscure the possible relationship between our in vitro investigated parameters and graft function, we performed a second evaluation in which patients who died within one week from (in our view) causes evidently not related to the quality of the liver were considered as a separate group of PNF.
Preparation of human hepatocytes and human liver slices
Preparation of human hepatocytes
Human hepatocytes were isolated using a modification of the method as described earlier by Groothuis et al. 7 ;the biopsy wedge was cannulated with 2-4 cannulas as was described. 9 supplemented with 1 % (w/v) bovine serum albumin (BSA). The liver capsula was cut and liver tissue was dissociated with the aid of a pair of forceps and subsequently filtered through 250, 100 and 50 µm nylon filters.
The cell suspensions were pooled and centrifuged at 50 g for 4 min and washed three times with ice-cold KHB. Non-viable cells were removed by Percoll density centrifugation 7 and the viability was assessed by trypan blue exclusion (final concentration 0.2%).
Preparation of human liver slices
From the pieces of liver tissue, cores (diameter 8 mm) were made as previously described 9 , and stored in ice-cold UW until slicing. The slicing was performed with the Krumdieck slicer. Ice-cold KHB supplemented with glucose to a final concentration of 25 mM was used as slice buffer. Human liver slices (200-300 µm thickness; wet weight 10 -14 mg) were prepared with standard settings (cycle speed 40; interrupted mode). After slicing the human liver slices were stored in UW until the start of the experiment.
Viability and function of hepatocytes
The viability of the hepatocytes was assessed by trypan blue exclusion and ATP content directly after isolation and after 30 minutes of incubation at 37 °C, as described earlier 9 . The uptake experiments with 21 µM of taurocholic acid in isolated human hepatocytes were performed as described by Sandker et al. 10 .
The rate constant for uptake (k in ) and excretion (k out ) of taurocholic acid were Chapter 4 75 calculated as described earlier 10 . To determine drug metabolism, hepatocytes (1.5 x 10 6 cells per ml in Krebs-Henseleit buffer (KHB) supplemented with 1 % BSA) were incubated with 5 mM lidocaine during 60 minutes as previously described 9 .
Viability and function of liver slices
Slices were incubated in 1.4 ml KHB supplemented to 25 mM glucose on stainless steel grids in 24 well tissue culture plates at 37 °C with separate magnetic stirrers and carbogen (95 % O 2 :5 % CO 2 ) supply in each well 9 . The potassium content was determined, after 1 hour incubation, as described by Fisher et al. 11 . Lidocaine was added to a final concentration of 5 mM and MEGX formation was measured after 60 minutes of incubation by HPLC 12 . The MEGX formation rate was expressed per 10 6 hepatocytes assuming that 100 x 10 6 hepatocytes are present per gram of human liver 13 .
Statistics
To compare means of the experiments the independent t-test or the nonparametric test (Mann-Whitney test) was used. Linear regression analysis was used to detect possible significance of correlation. The statistical package used was SPSS 6.0 statistical software. A p-value < 0.05 was considered statistically significant.
Results
We studied a group of 33 split or reduced size liver transplantations. Using the classification according to Ploeg et al. 8 
In vitro results
From 33 specimens obtained from split livers or reduced size livers, we prepared both hepatocytes and liver slices. In Table 1 , the number and viability (trypan blue exclusion) of hepatocytes derived from specimens of these different human livers is shown.
Both the yield before and after Percoll density centrifugation (used to remove non-viable cells) is presented. About 33 % (range=0.1-71 %; median=29%) of the totally isolated human hepatocytes were recovered after Percoll centrifugation.
These cells showed excellent viability (trypan blue exclusion 92 %).
The rate constants for uptake and excretion of the anionic bile acid taurocholic acid in hepatocytes and the energy status of the hepatocytes determined by the ATP content is depicted in Table 2 .
After 1 hour of incubation, the potassium concentration in the slices was 36.7 ± 3.7 nmol/ mg liver slice (n=15).
In Table 3 
Comparison of in vitro data
The viability of the cells assessed by the trypan blue exclusion test directly after the isolation correlated significantly with the yield of cells after the Percoll density centrifugation (r 2 =0.48, p=0.012). The yield of hepatocytes both before and after Percoll significantly correlated with MEGX ratio (respectively r 2 =0.43, p=0.008 and r 2 =0.49, p=0.011) (Figure 1 ), but not with the MEGX formation rate in cells or slices (data not shown). No correlation was found either between taurocholic acid uptake rate or ATP content and the yield of cells. In addition, the MEGX ratio did not correlate with taurocholic acid uptake or ATP content.
Prediction of liver function after transplantation
Comparison of in vitro with in vivo data
Bile production in the recipients (n=12-16) from day 3-6 correlated significantly with the yield of viable cells after Percoll centrifugation. If a high yield of hepatocytes after Percoll was found, the bile production in the recipient was high. The serum GOT on day 2 and 3 correlated significantly with the yield of cells before (n=28; p=0.042 for day 2 and n=26; p=0.028 for day 3) and after Percoll (n=22; p=0.017 for day 2 and n=20; p=0.02 for day 3). The serum GPT on day 2 correlated significantly with yield of cells after Percoll (n=22; p=0.044). The serum GOT and serum GPT in the recipient were high if the yield of hepatocytes after Percoll was high. All other parameters measured in the recipients during 7 days did not correlate with any of the in vitro parameters. 
Prediction of primary non-function by in vitro parameters
None of the viability tests of the in vitro preparations of the eight livers, which exhibited primary non-function after transplantation, were significantly different from those livers that showed good graft function after transplantation (Figure 1 and 2) . Furthermore, the second evaluation revealed that the four livers, which exhibited primary non-function according to the modified Ploeg et al. 8 classification (Figure 1 and 2), were also not significantly different from those livers with good graft function.
The four livers that were excluded from this modified Ploeg et al. 8 classification
were qualified as non-liver quality-related failure and were not significantly different from those livers that showed good graft function after transplantation ( Figure 2 ).
Discussion
Human hepatocytes or liver slices prepared from liver specimen obtained after split or reduced size transplantation offer a unique possibility to assess the in vitro function of the graft. This makes it possible to evaluate the potential Figure 2 The data in figure 2 were normalized by expressing the data of the PNF groups as percentage of the mean of the data of the group with good liver function post-transplantation (which is set at 100 %). Good post-transplantation function ( ); primary non-function according to Ploeg et al. (8) and where are the PNF with impaired liver function and the PNF due to non-liver quality-related failure. The amount of grafts used to study the in vitro tests in the different groups is given as n.
predictive value of in vitro tests for graft function, since the in vitro tests are performed on tissue from the same liver as that is transplanted. In addition, more insight may be given into the mechanisms leading to primary non-function.
Due to interindividual differences, MEGX production from lidocaine varies extensively in man, and this complicates the use of the MEGX test as in vivo viability test for donor livers. These interindividual differences in MEGX formation expressed per million hepatocytes are also observed in liver slices and in hepatocytes prepared from the same human liver 9 . Therefore, to normalize for the interindividual differences in MEGX formation, the MEGX ratio was calculated as the rate of MEGX production in the slice (expressed per million hepatocytes, present in the slice) divided by the MEGX formation in the isolated hepatocytes showing good post-operative function (Fig 2) .
Interestingly, it was observed that if the bile production was high in the recipient, the yield of viable hepatocytes from the same liver after Percoll separation was 81 also high. Supposing that the isolation procedure only selects the most viable cells, this high yield suggests a high amount of viable hepatocytes in the graft.
This apparent quality of the donor liver may ultimately lead to a better bile production in the graft. However, the serum GOT and GPT levels were significantly higher in the recipients receiving livers from which a high yield of hepatocytes However, major difficulties in correlating results obtained with in vitro tests with those of graft function may be unavoidable due to patient related factors such as age, severity of the disease, and complications due to the operation procedure.
In conclusion, the presently used in vitro tests, including the MEGX ratio , did not select non-viable livers. The incidents of primary non-function of the grafts, as determined by both classification occurred in spite of normal in vitro function tests indicating that these particular tests were not able to predict graft function.
These results indicate that either the function tests used in this study are not sensitive enough or that other factors than liver viability influenced the graft function of the recipient in this specific group of patients. These results are in 82 line with those of Groothuis et al. 7 ; they showed that from livers discarded for orthotopic transplantation, a comparable yield of viable hepatocytes was obtained with similar transport capacity for taurocholic acid and ATP content than from livers accepted for transplantation.
Non-parenchymal cells seem to be an important factor in reperfusion injury 15, 16 .
Therefore, in the future more attention should be paid to the activity of these non-parenchymal cells and the interaction between non-parenchymal and parenchymal cells. In our institute we are now studying the activity of non-parenchymal cells in the human liver slices. Human liver slices prepared from split or reduced size livers could offer an excellent human liver preparation, as this in vitro system represents an integrated liver system, which may be used to gain more insight in the mechanisms of primary non-function, reperfusion injury and to investigate whether predictive function tests should include the probing of non-parenchymal cell function.
